Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Magnosco logo — Pioneering non-invasive skin cancer detection with advanced...

Magnosco

Pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology

Founded 2014 11-50 employees Venture round Biotechnology, Health Care +1

General Information

Company Name Magnosco
Founded Year 2014
Employees 11-50
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Magnosco. To contact Magnosco, visit en.magnosco.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Magnosco compare?

A PDF of Magnosco and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Magnosco soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Magnosco

Magnosco is a biotechnology and healthcare startup founded in 2014 that is pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology. The company's slogan, "Pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology," underscores its commitment to early cancer detection. Magnosco's method for identifying early-stage malignant melanoma, called dermatofluoroscopy, is a non-invasive diagnostic approach that utilizes infrared laser and artificial intelligence technology. The startup's focus on early detection of skin cancer is not only promising for improved patient outcomes, but also aligns with the growing emphasis on preventative healthcare. Furthermore, the recent Venture Round investment at 11 March 2020 from Corecam Family Office and SPRIM Ventures indicates that investors recognize the potential of Magnosco's innovative approach. This reflects confidence in the company's technology and its prospects for addressing a significant healthcare need.

Business keywords: non-invasive diagnostics, skin cancer detection, early-stage melanoma, infrared laser technology, dermatofluoroscopy, laser spectroscopy, dermatology, cancer detection, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
Corecam Family Office
Corecam Family Office, SPRIM Ventures
11 Mar 2020

Magnosco Alternatives & Competitors

View All Alternatives
Magnosco vs
SciBase
SciBase Sweden

Pioneering prediction and prevention in dermatology

Venture round
42 employees
Biotechnology, Health Care
Compare Magnosco vs SciBase
Magnosco vs
MLA Diagnostics
MLA Diagnostics The Netherlands

A multi-parameter non-invasive melanoma risk assessment tool

Venture round
10 employees
Health Care, Medical Devices
Magnosco vs
VisionGate, Inc.
VisionGate, Inc. United States

Leading the Battle Against Lung Cancer through our Early Detection Technology

Venture round
24 employees
Biotechnology, Health Care
Also compare with: Magnosco vs Breathonix Pte Ltd Breathonix Pte Ltd View all alternatives

FAQ About Magnosco

Pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology
Magnosco was founded in 2014.
Magnosco operates in Biotechnology, Health Care and Medical Devices. Its work centres on non-invasive diagnostics, skin cancer detection, early-stage melanoma and infrared laser technology.
Magnosco has approximately 11-50 employees.
Magnosco has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Magnosco include SciBase, MLA Diagnostics, VisionGate, Inc., Breathonix Pte Ltd, Artificial Intelligence Expert. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Magnosco and SciBase are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Magnosco, https://bouncewatch.com/company/magnosco, updated 11 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes